Cite

HARVARD Citation

    Shueb, S. et al. (2019). Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5. Neuropharmacology. p. . [Online]. 
  
Back to record